Daniel Codallos, Jr

Title: The Innovative Contributions of Daniel Codallos, Jr.

Introduction

Daniel Codallos, Jr. is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions and dosage forms for cancer treatment. With a total of 2 patents to his name, Codallos is recognized for his innovative approach to addressing critical health issues.

Latest Patents

Codallos's latest patents focus on pharmaceutical compositions that include N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino) benzamide. These compositions are designed to be effective in treating subjects with cancer. The patents also detail methods for preparing these compositions and dosage forms, as well as methods for treating patients using these innovative formulations.

Career Highlights

Daniel Codallos, Jr. is currently associated with Ignyta, Inc., a company that focuses on precision medicine for cancer treatment. His work at Ignyta has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include Robert L. Orr and Ching-Yuan Li. Their collaborative efforts contribute to the advancement of pharmaceutical innovations aimed at improving patient outcomes.

Conclusion

Daniel Codallos, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in cancer treatment, highlight the importance of research and development in creating effective medical solutions.